Tekmira Pharmaceuticals Corporation to Webcast Presentation at the Piper Jaffray Health Care Conference

VANCOUVER, BRITISH COLUMBIA--(Marketwire - November 30, 2009) - Tekmira Pharmaceuticals Corporation (TSX: TKM), a leading developer of RNA interference (RNAi) therapeutics and proprietary delivery technology, announced today that the Company's President and Chief Executive Officer, Dr. Mark Murray, will present at the Piper Jaffray 21st Annual Health Care Conference on Tuesday December 1, 2009 at 9:30 am ET at the New York Palace Hotel in New York City. A webcast of the presentation will be available and can be accessed on the Company's website, www.tekmirapharm.com.

About Tekmira

Tekmira Pharmaceuticals Corporation is a biopharmaceutical company focused on advancing novel RNAi therapeutics and providing its leading lipid nanoparticle delivery technology to pharmaceutical partners. Further information about Tekmira can be found at www.tekmirapharm.com. Tekmira is based in Vancouver, B.C.